All In Biotech

Drug Trial Radar · NCT02734966

Efficacy and Safety Study of Magnesium Isoglycyrrhizinate Injection in Subjects With Acute Drug-induced Liver Injury

A Multi-center, Randomized, Double-blind, Active Control Phase II Study to Investigate Multiple Dosage and Treatments of Magnesium Isoglycyrrhizinate Injection to Cure the Acute Drug-induced Liver Injury

Last checked: Nov 19, 2026Latest source record: Sep 27, 2016 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 174 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

174

Actual

Start

Dec 2007

Primary completion

Dec 2008

Study completion Dec 2011

Sponsor

Sponsor type
Industry
First posted
Apr 12, 2016

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to investigate the safety, effective dosage and treatment of Magnesium Isolycyrrhizinate Injection to cure the acute drug-induced liver injury compared with the Tiopronin Injection.

Conditions

  • Drug-Induced Liver Injury

Interventions

  • Magnesium Isoglycyrrhizinate Injection 100mg ODDrug

    Magnesium Isoglycyrrhizinate Injection 100mg OD

  • Magnesium Isoglycyrrhizinate Injection 200mg ODDrug

    Magnesium Isoglycyrrhizinate Injection 200mg OD for 4 weeks

  • Tiopronin InjectionDrug

    Tiopronin Injection 200mg OD

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Rate of ALT normalization at week 4 of treatmentTime frame: 4 weeks

Locations

8 sites in 1 country. Site status is shown where the registry gives one.

  • Beijing Chest Hospital, Capital Medical University

    Beijing, Beijing Municipality, China

  • Nanjing Pulmonary Hospital

    Nanjing, Jiangsu, China

  • 85 Hospital of People's Liberation Army

    Shanghai, Shanghai Municipality, China

  • Renji Hospital Shanghai Jiaotong University School of Medicine

    Shanghai, Shanghai Municipality, China

  • Shanghai Pulmonary Hospital

    Shanghai, Shanghai Municipality, China

  • Shanghai Sixth People's Hospital

    Shanghai, Shanghai Municipality, China

  • Integrated Chinese and Western Medicine Hospital of Zhejiang Province

    Hangzhou, Zhejiang, China

  • Zhejiang Cancer Hospital

    Hangzhou, Zhejiang, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.